113 related articles for article (PubMed ID: 14680454)
21. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
[TBL] [Abstract][Full Text] [Related]
22. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
Garcia-Alloza M; Hirst WD; Chen CP; Lasheras B; Francis PT; Ramírez MJ
Neuropsychopharmacology; 2004 Feb; 29(2):410-6. PubMed ID: 14571255
[TBL] [Abstract][Full Text] [Related]
23. FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats.
Tokita K; Inoue T; Yamazaki S; Wang F; Yamaji T; Matsuoka N; Mutoh S
Eur J Pharmacol; 2005 Dec; 527(1-3):111-20. PubMed ID: 16325809
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
25. The Protective Effects of IGF-I against β-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A.
Aguado-Llera D; Canelles S; Frago LM; Chowen JA; Argente J; Arilla E; Barrios V
Neuroscience; 2018 Mar; 374():104-118. PubMed ID: 29406271
[TBL] [Abstract][Full Text] [Related]
26. Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.
Gejl M; Brock B; Egefjord L; Vang K; Rungby J; Gjedde A
Sci Rep; 2017 Dec; 7(1):17490. PubMed ID: 29235507
[TBL] [Abstract][Full Text] [Related]
27. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
Lin AP; Shic F; Enriquez C; Ross BD
MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
[TBL] [Abstract][Full Text] [Related]
28. Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.
Huang Y; Guo B; Shi B; Gao Q; Zhou Q
J Alzheimers Dis; 2018; 63(3):1089-1107. PubMed ID: 29710701
[TBL] [Abstract][Full Text] [Related]
29. Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer's Disease via Angiotensin AT1 Receptor.
Nakagawa T; Hasegawa Y; Uekawa K; Senju S; Nakagata N; Matsui K; Kim-Mitsuyama S
Am J Hypertens; 2017 Feb; 30(2):141-150. PubMed ID: 27572961
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment.
Haxby JV; Rapoport SI
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):427-38. PubMed ID: 3541045
[TBL] [Abstract][Full Text] [Related]
31. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
32. Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease.
Kume K; Hanyu H; Sakurai H; Takada Y; Onuma T; Iwamoto T
Geriatr Gerontol Int; 2012 Apr; 12(2):207-14. PubMed ID: 21929736
[TBL] [Abstract][Full Text] [Related]
33. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
34. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
35. Increase by FK960, a novel cognitive enhancer, in glial cell line-derived neurotrophic factor production in cultured rat astrocytes.
Koyama Y; Egawa H; Osakada M; Baba A; Matsuda T
Biochem Pharmacol; 2004 Jul; 68(2):275-82. PubMed ID: 15193999
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
Yoshida T; Ha-Kawa S; Yoshimura M; Nobuhara K; Kinoshita T; Sawada S
Ann Nucl Med; 2007 Jul; 21(5):257-65. PubMed ID: 17634843
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.
Kalaria RN; Harik SI
Prog Clin Biol Res; 1989; 317():415-21. PubMed ID: 2602426
[TBL] [Abstract][Full Text] [Related]
38. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?
de la Torre JC
Ann N Y Acad Sci; 2000 Apr; 903():424-36. PubMed ID: 10818533
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
Kamat PK; Kyles P; Kalani A; Tyagi N
Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
